CureVac NV Q3 2024 Earnings Call Transcript - Thomson StreetEvents

CureVac NV Q3 2024 Earnings Call Transcript

CureVac NV Q3 2024 Earnings Call Transcript - Thomson StreetEvents
CureVac NV Q3 2024 Earnings Call Transcript
Published Nov 12, 2024
12 pages (7737 words) — Published Nov 12, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CVAC.OQ earnings conference call or presentation 12-Nov-24 2:00pm GMT

  
Brief Excerpt:

...Editor Portions of this transcript marked (audio in progress) indicate audio problems. The missing text will be supplied if a replay becomes available. Sarah Fakih ...

  
Report Type:

Transcript

Source:
Company:
CureVac NV
Ticker
CVAC.OQ
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Charlie Yang - BofA Global Research - Analyst : Great. Thanks for taking the question. I have two, please. I think one; can you discuss perhaps kind of your thoughts about business opportunity, licensing opportunity outside of the mRNA kind of your core expertise. Whether that is an area of kind of potential interest just given your cash position? And then second of all, can you discuss about the kind of the litigation update and kind of what should we expect on that front? Thank you.


Question: Charlie Yang - BofA Global Research - Analyst : Thank you.


Question: Roy Buchanan - Citizens JMP - Analyst : Hey. Thanks for taking the questions. Just a couple of FimH questions. I think there was a prior protein-based program that didn't move forward. Can you just maybe comment on if your engineering approaches address maybe why that program didn't move forward? And then any thoughts on how you -- I think there's a glyco conjugate program in Phase 3. Any thoughts on how your approach could be better than that? Thanks.


Question: Roy Buchanan - Citizens JMP - Analyst : Okay, great. And the design was all in house or did you in-license any technology? Thanks. That's it. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 12, 2024 / 2:00PM, CVAC.OQ - Q3 2024 CureVac NV Earnings Call


Question: Roy Buchanan - Citizens JMP - Analyst : Got it. Thank you.

Table Of Contents

CureVac NV Q4 2024 Earnings Call Transcript – 2025-04-10 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 10-Apr-25 1:00pm GMT

CureVac NV Q3 2023 Earnings Call Transcript – 2023-11-14 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 14-Nov-23 2:00pm GMT

CureVac NV at Bank of America Global Healthcare Conference Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of CVAC.OQ presentation 9-May-23 10:40pm GMT

CureVac NV Q4 2022 Earnings Call Transcript – 2023-04-25 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 25-Apr-23 1:00pm GMT

CureVac NV Annual Shareholders Meeting Transcript – 2023-03-28 – US$ 54.00 – Edited Transcript of CVAC.OQ shareholder or annual meeting 28-Mar-23 10:59am GMT

CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript – 2023-01-06 – US$ 54.00 – Edited Transcript of CVAC.OQ conference call or presentation 6-Jan-23 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "CureVac NV Q3 2024 Earnings Call Transcript" Nov 12, 2024. Alacra Store. May 02, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2024-CureVac-NV-Earnings-Call-T16175290>
  
APA:
Thomson StreetEvents. (2024). CureVac NV Q3 2024 Earnings Call Transcript Nov 12, 2024. New York, NY: Alacra Store. Retrieved May 02, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2024-CureVac-NV-Earnings-Call-T16175290>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.